How we use recombinant activated factor VII in patients with haemophilia A or B complicated by inhibitors. Working group of hematology experts from Australia and New Zealand, Melbourne, April 2011 - Brown, S A; Barnes, C; Curtin, J (Intern Med J, 2012)
, et al; Hematology working group.